Patients with rare diseases in war conditions are most likely to face the risk of shortage or delay in the supply of imported drugs, disruption of the treatment process, and increase in medical and living costs. Since many of these patients require constant use of medicine and specialized care, any disruption in the supply chain of medicine, transportation, communication or medical services can endanger their health and even their lives.